SODIUM CHLORIDE

SODIUM CHLORIDE was reported 81362 times

SODIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 120 0.3960
1 DEVICE WIRELESS COMMUNICATION ISSUE 87 0.3359
2 SLEEP DISORDER THERAPY 57 0.2879
3 DEAFNESS PERMANENT 56 0.2857
4 DEVICE MAINTENANCE ISSUE 130 0.2211
5 INFUSION SITE DISCHARGE 315 0.1795
6 GRANULOCYTE COUNT DECREASED 324 0.1746
7 ANALGESIC THERAPY 54 0.1682
8 MYELOSUPPRESSION 5538 0.1536
9 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 802 0.1472
10 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 121 0.1355
11 EJECTION FRACTION 78 0.1343
12 OSMOTIC DEMYELINATION SYNDROME 99 0.1341
13 SENSITISATION 99 0.1304
14 DEVICE INFUSION ISSUE 317 0.1277
15 INFUSION SITE HAEMORRHAGE 400 0.1215
16 INFUSION SITE IRRITATION 148 0.1152
17 INFUSION SITE DISCOMFORT 112 0.1080
18 ENDOCRINE OPHTHALMOPATHY 90 0.1037
19 CYSTIC FIBROSIS 543 0.0980
20 ACIDOSIS HYPERCHLORAEMIC 58 0.0976
21 INFUSION SITE SWELLING 615 0.0976
22 INFUSION SITE PAIN 1233 0.0956
23 INFUSION SITE DISCOLOURATION 83 0.0943
24 INFUSION SITE INDURATION 139 0.0937
25 INFUSION SITE WARMTH 114 0.0930
26 INFUSION SITE MASS 101 0.0929
27 INFUSION SITE ERYTHEMA 770 0.0912
28 INFUSION SITE INFLAMMATION 64 0.0907
29 INFUSION SITE INFECTION 205 0.0881
30 INFUSION SITE PRURITUS 275 0.0871
31 INFUSION SITE BRUISING 174 0.0805
32 HEREDITARY ANGIOEDEMA 855 0.0796
33 INFUSION SITE RASH 109 0.0794
34 FEMALE GENITAL TRACT FISTULA 130 0.0761
35 INCORRECT PRODUCT FORMULATION ADMINISTERED 63 0.0712
36 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 62 0.0669
37 BLOOD FIBRINOGEN DECREASED 76 0.0665
38 CHRONIC SINUSITIS 250 0.0665
39 CATHETER SITE SWELLING 61 0.0652
40 VASCULAR DEVICE INFECTION 292 0.0643
41 INFUSION SITE NODULE 61 0.0635
42 POLYCYSTIC OVARIES 97 0.0625
43 HYPERPYREXIA 263 0.0621
44 INCORRECT DRUG ADMINISTRATION RATE 264 0.0620
45 MATERNAL EXPOSURE DURING DELIVERY 58 0.0585
46 INFUSION SITE REACTION 174 0.0582
47 SPUTUM INCREASED 125 0.0577
48 DISORGANISED SPEECH 101 0.0547
49 EJECTION FRACTION ABNORMAL 66 0.0538
50 HYPERPHOSPHATAEMIA 115 0.0534
51 INFUSION SITE EXTRAVASATION 329 0.0528
52 OBSTRUCTIVE SLEEP APNOEA SYNDROME 75 0.0514
53 RADICULOPATHY 135 0.0512
54 CATHETER SITE DISCHARGE 57 0.0507
55 CATHETER SITE PAIN 130 0.0501
56 OVARIAN HYPERSTIMULATION SYNDROME 113 0.0484
57 PROCTITIS 131 0.0467
58 POOR VENOUS ACCESS 482 0.0465
59 ARTERIAL HAEMORRHAGE 53 0.0464
60 DEVICE ALARM ISSUE 84 0.0462
61 CATHETER SITE ERYTHEMA 99 0.0462
62 HYPERNATRAEMIA 226 0.0453
63 MACULAR DEGENERATION 527 0.0441
64 INSURANCE ISSUE 673 0.0440
65 HYPERVOLAEMIA 213 0.0431
66 DERMATITIS CONTACT 484 0.0424
67 NEUTROPHIL COUNT DECREASED 1679 0.0412
68 VEIN RUPTURE 68 0.0406
69 MULTIPLE ALLERGIES 318 0.0405
70 CATHETER SITE HAEMORRHAGE 101 0.0403
71 TACHYPNOEA 540 0.0397
72 PULMONARY FUNCTION TEST DECREASED 171 0.0390
73 TEMPERATURE INTOLERANCE 386 0.0374
74 RHINOVIRUS INFECTION 142 0.0364
75 BODY TEMPERATURE ABNORMAL 67 0.0364
76 SEASONAL ALLERGY 512 0.0361
77 PNEUMONIA PSEUDOMONAL 55 0.0358
78 DEVICE POWER SOURCE ISSUE 102 0.0349
79 AORTIC VALVE STENOSIS 61 0.0342
80 HAEMATOLOGICAL INFECTION 83 0.0339
81 DEVICE RELATED SEPSIS 66 0.0328
82 TETANY 58 0.0318
83 RESPIRATORY SYMPTOM 90 0.0316
84 CENTRAL VENOUS CATHETERISATION 95 0.0315
85 OXYGEN CONSUMPTION INCREASED 74 0.0309
86 NEPHROGENIC ANAEMIA 139 0.0300
87 DEVICE CONNECTION ISSUE 62 0.0294
88 RHINITIS ALLERGIC 130 0.0292
89 DEAFNESS NEUROSENSORY 96 0.0292
90 PRODUCT PACKAGING CONFUSION 70 0.0288
91 HEPATIC FUNCTION ABNORMAL 1076 0.0288
92 TRAUMATIC HAEMORRHAGE 54 0.0287
93 BLOOD PHOSPHORUS INCREASED 77 0.0282
94 BLOOD CHLORIDE DECREASED 72 0.0279
95 OBSTRUCTION 111 0.0278
96 BREATH SOUNDS ABNORMAL 136 0.0276
97 BICYTOPENIA 54 0.0275
98 WHITE BLOOD CELL COUNT DECREASED 2979 0.0275
99 INFUSION RELATED REACTION 1730 0.0261
100 BRONCHIECTASIS 174 0.0258
101 RESPIRATORY TRACT INFECTION 672 0.0258
102 CYTOKINE RELEASE SYNDROME 516 0.0257
103 AORTIC ARTERIOSCLEROSIS 66 0.0256
104 HYPERPARATHYROIDISM SECONDARY 64 0.0255
105 DISTURBANCE IN SOCIAL BEHAVIOUR 60 0.0254
106 PSEUDOMONAS INFECTION 216 0.0252
107 INCREASED BRONCHIAL SECRETION 64 0.0250
108 GRANULOCYTOPENIA 141 0.0247
109 DYSPHORIA 125 0.0247
110 SKIN ABRASION 116 0.0245
111 TACHYARRHYTHMIA 61 0.0244
112 OXYGEN SATURATION ABNORMAL 69 0.0243
113 RALES 140 0.0241
114 AGRANULOCYTOSIS 441 0.0237
115 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 118 0.0233
116 PRODUCT DISTRIBUTION ISSUE 215 0.0232
117 MYASTHENIA GRAVIS 185 0.0229
118 BLOOD SODIUM INCREASED 61 0.0226
119 HAEMOGLOBIN INCREASED 103 0.0226
120 PLEURITIC PAIN 61 0.0221
121 MYCOBACTERIUM AVIUM COMPLEX INFECTION 59 0.0220
122 ACUTE RESPIRATORY FAILURE 418 0.0217
123 HYPOPHOSPHATAEMIA 158 0.0214
124 PRODUCT CONTAMINATION 75 0.0210
125 RESPIRATORY SYNCYTIAL VIRUS INFECTION 182 0.0209
126 UPPER RESPIRATORY TRACT INFECTION 963 0.0208
127 ORAL CANDIDIASIS 274 0.0208
128 HEPATIC CYST 70 0.0206
129 WOUND DEHISCENCE 69 0.0204
130 ANAPHYLACTOID REACTION 84 0.0204
131 ENDOTRACHEAL INTUBATION 57 0.0203
132 RESPIRATORY RATE INCREASED 179 0.0201
133 HYPONATRAEMIA 1127 0.0200
134 FIBRIN D DIMER INCREASED 71 0.0200
135 PARAESTHESIA ORAL 288 0.0199
136 EAR INFECTION 531 0.0199
137 HYPOVOLAEMIA 115 0.0196
138 PRODUCTIVE COUGH 936 0.0196
139 BLOOD CREATININE DECREASED 61 0.0195
140 DIVERTICULUM INTESTINAL 85 0.0194
141 HYPOXIA 676 0.0192
142 COVID-19 PNEUMONIA 225 0.0190
143 SINUSITIS 1944 0.0189
144 TROPONIN INCREASED 144 0.0189
145 LUNG TRANSPLANT 67 0.0189
146 PARANASAL SINUS DISCOMFORT 71 0.0187
147 ATELECTASIS 181 0.0187
148 PURULENT DISCHARGE 80 0.0187
149 OXYGEN SATURATION DECREASED 1048 0.0186
150 CATHETER SITE INFECTION 69 0.0182
151 POSTOPERATIVE WOUND INFECTION 123 0.0182
152 WEIGHT FLUCTUATION 190 0.0181
153 SPUTUM DISCOLOURED 172 0.0181
154 DEVICE OCCLUSION 255 0.0181
155 SKIN LACERATION 197 0.0181
156 RESPIRATORY ACIDOSIS 71 0.0180
157 PNEUMONIA FUNGAL 71 0.0180
158 BLOOD SODIUM DECREASED 339 0.0180
159 PNEUMONIA VIRAL 57 0.0179
160 GASTROINTESTINAL INFECTION 160 0.0178
161 HYPOKALAEMIA 823 0.0178
162 BRAIN HERNIATION 53 0.0177
163 LIVER INJURY 433 0.0176
164 PRODUCT PREPARATION ISSUE 115 0.0175
165 DRUG ERUPTION 310 0.0175
166 BRAIN DEATH 54 0.0175
167 HAEMARTHROSIS 155 0.0173
168 LARYNGEAL OEDEMA 106 0.0172
169 BONE MARROW FAILURE 348 0.0171
170 PHARYNGITIS STREPTOCOCCAL 185 0.0171
171 CHEST DISCOMFORT 1745 0.0170
172 PNEUMONIA BACTERIAL 156 0.0170
173 TOXIC EPIDERMAL NECROLYSIS 257 0.0169
174 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 100 0.0169
175 SINUS CONGESTION 228 0.0169
176 GASTROENTERITIS VIRAL 303 0.0168
177 LEFT VENTRICULAR DYSFUNCTION 111 0.0166
178 MENINGITIS ASEPTIC 74 0.0165
179 PROTEIN TOTAL DECREASED 62 0.0164
180 IRON DEFICIENCY 74 0.0164
181 BACTERAEMIA 195 0.0164
182 PRODUCT LEAKAGE 92 0.0164
183 VENTRICULAR FIBRILLATION 182 0.0164
184 BLOOD ALBUMIN DECREASED 129 0.0162
185 BACTERIAL INFECTION 303 0.0162
186 BLOOD URIC ACID INCREASED 93 0.0161
187 HAEMORRHAGE SUBCUTANEOUS 57 0.0161
188 TRANSAMINASES INCREASED 357 0.0160
189 EAR PRURITUS 56 0.0160
190 LYMPHOCYTE COUNT DECREASED 282 0.0159
191 TENDERNESS 166 0.0159
192 DEVICE RELATED INFECTION 244 0.0158
193 EXTRAVASATION 65 0.0158
194 AORTIC STENOSIS 55 0.0158
195 CYANOSIS 248 0.0158
196 CYTOPENIA 192 0.0157
197 DRUG-INDUCED LIVER INJURY 490 0.0156
198 CHILLS 1822 0.0155
199 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 59 0.0154
200 SKIN INFECTION 173 0.0154
201 FULL BLOOD COUNT ABNORMAL 162 0.0153
202 BLOOD TEST ABNORMAL 215 0.0153
203 NEUTROPENIC SEPSIS 109 0.0152
204 TUMOUR LYSIS SYNDROME 134 0.0152
205 CARDIOGENIC SHOCK 218 0.0152
206 VIRAL INFECTION 505 0.0152
207 HAEMOPTYSIS 423 0.0151
208 ELECTROLYTE IMBALANCE 176 0.0151
209 OLIGURIA 94 0.0151
210 HYPOALBUMINAEMIA 117 0.0150
211 NEUTROPHIL COUNT INCREASED 154 0.0150
212 FAILURE TO THRIVE 78 0.0150
213 BODY TEMPERATURE INCREASED 304 0.0149
214 PULMONARY HYPERTENSION 309 0.0148
215 BLOOD PHOSPHORUS DECREASED 54 0.0148
216 PAPULE 104 0.0147
217 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 151 0.0147
218 END STAGE RENAL DISEASE 268 0.0147
219 PARANASAL SINUS HYPERSECRETION 56 0.0147
220 RESPIRATORY TRACT CONGESTION 233 0.0147
221 PALLOR 398 0.0146
222 SUSPECTED OFF LABEL USE 66 0.0146
223 STAPHYLOCOCCAL SEPSIS 72 0.0146
224 URINE OUTPUT DECREASED 127 0.0145
225 EYE INFECTION 164 0.0145
226 STREPTOCOCCAL INFECTION 80 0.0144
227 FEBRILE NEUTROPENIA 951 0.0143
228 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 244 0.0142
229 PLATELET COUNT DECREASED 1506 0.0141
230 ESCHERICHIA INFECTION 116 0.0141
231 SINUS TACHYCARDIA 200 0.0141
232 BLOOD PRESSURE SYSTOLIC DECREASED 64 0.0141
233 HYPERCALCAEMIA 173 0.0140
234 TRICUSPID VALVE INCOMPETENCE 111 0.0140
235 LIGAMENT SPRAIN 138 0.0139
236 BRAIN OEDEMA 176 0.0139
237 ACUTE PULMONARY OEDEMA 78 0.0139
238 HYPOMAGNESAEMIA 193 0.0138
239 MALNUTRITION 155 0.0138
240 FULL BLOOD COUNT DECREASED 279 0.0138
241 PNEUMOTHORAX 218 0.0137
242 MUSCLE HAEMORRHAGE 55 0.0137
243 CANDIDA INFECTION 230 0.0136
244 DYSPNOEA EXERTIONAL 512 0.0136
245 PAIN IN JAW 384 0.0135
246 ANAPHYLACTIC SHOCK 348 0.0135
247 RED CELL DISTRIBUTION WIDTH INCREASED 56 0.0135
248 PULSE ABSENT 64 0.0134
249 ASPIRATION 147 0.0134
250 VEIN DISORDER 67 0.0134
251 VAGINAL DISCHARGE 135 0.0133
252 FAECALOMA 73 0.0133
253 MOUTH HAEMORRHAGE 97 0.0132
254 MOUTH ULCERATION 277 0.0131
255 TOOTH INFECTION 173 0.0131
256 PYREXIA 4523 0.0131
257 HYPOCALCAEMIA 246 0.0130
258 PULSELESS ELECTRICAL ACTIVITY 54 0.0129
259 SINUS DISORDER 253 0.0128
260 PNEUMONIA ASPIRATION 319 0.0128
261 SECRETION DISCHARGE 158 0.0126
262 PRODUCT ADMINISTRATION INTERRUPTED 99 0.0126
263 BENIGN PROSTATIC HYPERPLASIA 65 0.0126
264 PROTHROMBIN TIME PROLONGED 75 0.0125
265 DECUBITUS ULCER 102 0.0125
266 BLOOD MAGNESIUM DECREASED 108 0.0125
267 BLOOD CALCIUM DECREASED 140 0.0124
268 SEPSIS 1382 0.0124
269 PULMONARY ARTERIAL HYPERTENSION 178 0.0123
270 GROIN PAIN 107 0.0122
271 FOOD POISONING 65 0.0121
272 BRONCHITIS 898 0.0121
273 ENTEROCOLITIS 70 0.0121
274 OROPHARYNGEAL DISCOMFORT 109 0.0121
275 HYPERLIPIDAEMIA 144 0.0120
276 RENAL TUBULAR NECROSIS 118 0.0120
277 SMALL INTESTINAL OBSTRUCTION 148 0.0120
278 BLOOD UREA INCREASED 201 0.0120
279 APPENDICITIS 110 0.0118
280 COAGULOPATHY 195 0.0117
281 INFLAMMATORY MARKER INCREASED 58 0.0117
282 TOXIC ENCEPHALOPATHY 59 0.0116
283 DISEASE COMPLICATION 53 0.0116
284 HEPARIN-INDUCED THROMBOCYTOPENIA 57 0.0116
285 UNRESPONSIVE TO STIMULI 295 0.0114
286 RESPIRATORY FAILURE 829 0.0114
287 BLOOD BILIRUBIN INCREASED 307 0.0114
288 PROCTALGIA 73 0.0113
289 SKIN WARM 66 0.0113
290 COVID-19 1990 0.0113
291 ARTHROPOD BITE 84 0.0113
292 ILLNESS 1165 0.0113
293 UPPER-AIRWAY COUGH SYNDROME 93 0.0113
294 ACIDOSIS 86 0.0112
295 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 191 0.0112
296 RESPIRATORY DISTRESS 310 0.0112
297 PROCEDURAL PAIN 311 0.0112
298 PNEUMONIA 3627 0.0112
299 ASPARTATE AMINOTRANSFERASE INCREASED 595 0.0112
300 LUNG INFECTION 174 0.0112
301 STAPHYLOCOCCAL INFECTION 369 0.0112
302 UROSEPSIS 103 0.0112
303 FOOD ALLERGY 86 0.0111
304 EPILEPSY 340 0.0111
305 APLASTIC ANAEMIA 58 0.0111
306 DEVICE PHYSICAL PROPERTY ISSUE 85 0.0111
307 GENERALISED OEDEMA 137 0.0111
308 ASCITES 325 0.0110
309 EAR DISCOMFORT 113 0.0110
310 PULMONARY CONGESTION 145 0.0110
311 CARPAL TUNNEL SYNDROME 154 0.0110
312 MULTIPLE ORGAN DYSFUNCTION SYNDROME 311 0.0110
313 BLOOD PRESSURE ABNORMAL 218 0.0110
314 COMPLICATION ASSOCIATED WITH DEVICE 159 0.0109
315 ECCHYMOSIS 75 0.0109
316 LEUKOCYTOSIS 197 0.0109
317 WHEEZING 645 0.0109
318 ABDOMINAL TENDERNESS 54 0.0109
319 MITRAL VALVE INCOMPETENCE 123 0.0109
320 DELIRIUM 377 0.0109
321 DERMATITIS ALLERGIC 136 0.0108
322 ANURIA 93 0.0108
323 KIDNEY INFECTION 211 0.0107
324 LIMB INJURY 292 0.0107
325 SLEEP APNOEA SYNDROME 205 0.0107
326 URINARY TRACT INFECTION 1831 0.0107
327 HICCUPS 88 0.0107
328 BLOOD PRESSURE DECREASED 710 0.0107
329 SEPTIC SHOCK 462 0.0106
330 NEURALGIA 257 0.0106
331 COLITIS 400 0.0105
332 CONCOMITANT DISEASE AGGRAVATED 65 0.0105
333 BLOOD CALCIUM INCREASED 92 0.0105
334 ACUTE KIDNEY INJURY 1604 0.0105
335 POST PROCEDURAL INFECTION 85 0.0104
336 SENSITIVE SKIN 77 0.0104
337 HEART RATE ABNORMAL 58 0.0104
338 MENINGITIS 69 0.0103
339 JOINT INJURY 220 0.0103
340 RHINITIS 83 0.0103
341 APPETITE DISORDER 68 0.0102
342 ADRENAL INSUFFICIENCY 124 0.0102
343 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 532 0.0102
344 HIATUS HERNIA 132 0.0102
345 NASAL CONGESTION 598 0.0102
346 METABOLIC ACIDOSIS 325 0.0102
347 FLANK PAIN 95 0.0101
348 RIGHT VENTRICULAR FAILURE 71 0.0101
349 COUGH 2839 0.0101
350 INFECTION 1465 0.0101
351 NEPHROPATHY TOXIC 113 0.0101
352 COLD SWEAT 177 0.0100
353 GINGIVAL BLEEDING 137 0.0100
354 ALANINE AMINOTRANSFERASE INCREASED 616 0.0100
355 PULMONARY MASS 149 0.0100
356 INFLUENZA 1107 0.0099
357 SUPRAVENTRICULAR TACHYCARDIA 95 0.0099
358 HYPERKALAEMIA 347 0.0099
359 HYPOTENSION 1982 0.0099
360 FLUSHING 1003 0.0099
361 RED BLOOD CELL COUNT DECREASED 282 0.0099
362 DEVICE FAILURE 150 0.0098
363 ASPERGILLUS INFECTION 64 0.0097
364 LOWER RESPIRATORY TRACT INFECTION 442 0.0097
365 TACHYCARDIA 860 0.0097
366 EAR PAIN 188 0.0097
367 ATRIAL FLUTTER 77 0.0096
368 CLOSTRIDIUM DIFFICILE COLITIS 102 0.0096
369 BLOOD PRESSURE DIASTOLIC DECREASED 71 0.0096
370 CARDIAC FAILURE ACUTE 64 0.0096
371 MUSCLE STRAIN 83 0.0096
372 DISSEMINATED INTRAVASCULAR COAGULATION 135 0.0096
373 RESPIRATION ABNORMAL 66 0.0096
374 MUSCULOSKELETAL CHEST PAIN 148 0.0096
375 PLEURAL EFFUSION 580 0.0095
376 HAEMATOCRIT DECREASED 189 0.0095
377 BLOOD POTASSIUM DECREASED 286 0.0095
378 BLOOD ALKALINE PHOSPHATASE INCREASED 235 0.0095
379 JOINT DISLOCATION 100 0.0095
380 ENCEPHALOPATHY 231 0.0094
381 WOUND INFECTION 103 0.0094
382 SCOLIOSIS 58 0.0094
383 PULMONARY OEDEMA 418 0.0093
384 RESPIRATORY DISORDER 278 0.0093
385 LUNG INFILTRATION 82 0.0093
386 CELLULITIS 467 0.0093
387 SINUS HEADACHE 55 0.0092
388 SWELLING OF EYELID 58 0.0092
389 TOOTH ABSCESS 94 0.0092
390 ANAL INCONTINENCE 83 0.0092
391 CIRCULATORY COLLAPSE 157 0.0092
392 UPPER GASTROINTESTINAL HAEMORRHAGE 155 0.0092
393 HYPERBILIRUBINAEMIA 95 0.0092
394 POST PROCEDURAL COMPLICATION 175 0.0091
395 HAEMATURIA 312 0.0091
396 HYDRONEPHROSIS 68 0.0091
397 PULMONARY HAEMORRHAGE 71 0.0091
398 DYSPNOEA 5137 0.0091
399 LUNG DISORDER 444 0.0091
400 ABDOMINAL DISTENSION 945 0.0090
401 ELECTROCARDIOGRAM ABNORMAL 71 0.0090
402 HAEMOGLOBIN DECREASED 929 0.0090
403 CONCUSSION 70 0.0090
404 FREQUENT BOWEL MOVEMENTS 244 0.0090
405 ANAPHYLACTIC REACTION 499 0.0090
406 PHARYNGITIS 112 0.0090
407 GOUT 162 0.0090
408 MICTURITION URGENCY 103 0.0090
409 LOCALISED INFECTION 218 0.0090
410 PERICARDIAL EFFUSION 208 0.0090
411 BRAIN FOG 141 0.0090
412 OEDEMA 487 0.0090
413 RASH ERYTHEMATOUS 429 0.0090
414 FUNGAL INFECTION 299 0.0090
415 EPISTAXIS 671 0.0090
416 MENTAL STATUS CHANGES 249 0.0090
417 IMPAIRED QUALITY OF LIFE 128 0.0089
418 PERIPHERAL COLDNESS 122 0.0089
419 PETECHIAE 92 0.0088
420 VOMITING 4137 0.0088
421 POLYURIA 72 0.0088
422 PHARYNGEAL SWELLING 86 0.0088
423 VENTRICULAR TACHYCARDIA 145 0.0088
424 HEART RATE INCREASED 869 0.0088
425 PRODUCT ADMINISTRATION ERROR 177 0.0087
426 NASOPHARYNGITIS 1606 0.0087
427 ERYTHEMA MULTIFORME 81 0.0087
428 CONJUNCTIVITIS 161 0.0087
429 PANCYTOPENIA 485 0.0087
430 CYSTITIS 276 0.0087
431 IRON DEFICIENCY ANAEMIA 80 0.0087
432 BODY TEMPERATURE DECREASED 85 0.0086
433 OBSTRUCTIVE AIRWAYS DISORDER 96 0.0086
434 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1555 0.0086
435 ANAEMIA 1642 0.0086
436 C-REACTIVE PROTEIN INCREASED 313 0.0086
437 WRONG PRODUCT ADMINISTERED 58 0.0086
438 PRODUCT USE COMPLAINT 135 0.0086
439 ABNORMAL FAECES 70 0.0085
440 THROAT IRRITATION 383 0.0085
441 HYPOTHYROIDISM 271 0.0085
442 BRONCHOSPASM 121 0.0085
443 LEUKOPENIA 424 0.0085
444 HAND FRACTURE 60 0.0085
445 ILEUS 105 0.0084
446 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 63 0.0084
447 OEDEMA PERIPHERAL 1023 0.0084
448 DEHYDRATION 1118 0.0084
449 BLOOD CREATININE INCREASED 546 0.0084
450 POOR QUALITY DRUG ADMINISTERED 54 0.0083
451 GASTROOESOPHAGEAL REFLUX DISEASE 667 0.0083
452 CLOSTRIDIUM DIFFICILE INFECTION 180 0.0082
453 RASH MACULO-PAPULAR 183 0.0082
454 HEAD INJURY 260 0.0082
455 HYPERTRANSAMINASAEMIA 57 0.0082
456 PNEUMONITIS 223 0.0082
457 SINUS BRADYCARDIA 79 0.0082
458 HYPERGLYCAEMIA 297 0.0081
459 OROPHARYNGEAL PAIN 753 0.0081
460 PRODUCT PREPARATION ERROR 166 0.0081
461 SCAB 92 0.0081
462 FEELING COLD 224 0.0080
463 HEPATOMEGALY 79 0.0080
464 RETCHING 171 0.0080
465 RHINORRHOEA 518 0.0080
466 VITAMIN D DEFICIENCY 78 0.0080
467 ULCER 127 0.0080
468 BRAIN INJURY 80 0.0080
469 FLUID OVERLOAD 116 0.0080
470 APNOEA 62 0.0080
471 FLUID RETENTION 405 0.0080
472 DIZZINESS POSTURAL 77 0.0079
473 ABDOMINAL PAIN 1847 0.0079
474 TORSADE DE POINTES 62 0.0079
475 HYPOAESTHESIA ORAL 119 0.0079
476 DECREASED APPETITE 1833 0.0079
477 FOOT FRACTURE 149 0.0079
478 GAMMA-GLUTAMYLTRANSFERASE INCREASED 174 0.0078
479 CARDIOTOXICITY 70 0.0078
480 BLOOD PRESSURE INCREASED 1188 0.0078
481 HAEMODYNAMIC INSTABILITY 59 0.0077
482 EMPHYSEMA 78 0.0077
483 OSTEOPENIA 117 0.0077
484 GASTROINTESTINAL DISORDER 690 0.0077
485 EOSINOPHIL COUNT INCREASED 64 0.0077
486 HEART RATE DECREASED 269 0.0077
487 EYELID OEDEMA 89 0.0076
488 HAEMATOMA 198 0.0076
489 BLOOD POTASSIUM INCREASED 124 0.0076
490 WHITE BLOOD CELL COUNT INCREASED 293 0.0076
491 HEPATIC FAILURE 230 0.0076
492 SPINAL OSTEOARTHRITIS 67 0.0076
493 WEIGHT DECREASED 2125 0.0076
494 THROMBOCYTOPENIA 850 0.0076
495 ASPHYXIA 62 0.0076
496 CARDIAC ARREST 627 0.0076
497 NEUROTOXICITY 133 0.0076
498 EMBOLISM 63 0.0076
499 LOWER GASTROINTESTINAL HAEMORRHAGE 56 0.0076
500 PRODUCT DOSE OMISSION ISSUE 2227 0.0076
501 INTERNAL HAEMORRHAGE 86 0.0075
502 MIGRAINE 717 0.0075
503 THERAPY NON-RESPONDER 337 0.0075
504 BRADYCARDIA 397 0.0075
505 HAEMORRHOIDS 146 0.0075
506 BRONCHOPULMONARY ASPERGILLOSIS 58 0.0075
507 HYPOPHAGIA 191 0.0075
508 STEVENS-JOHNSON SYNDROME 166 0.0075
509 SEIZURE 861 0.0074
510 HEADACHE 4666 0.0074
511 THERAPY PARTIAL RESPONDER 116 0.0074
512 MYOCARDITIS 85 0.0074
513 INTENTIONAL DOSE OMISSION 211 0.0074
514 NEPHROPATHY 69 0.0074
515 INCONTINENCE 78 0.0074
516 NAUSEA 5824 0.0074
517 WRIST FRACTURE 88 0.0073
518 RECTAL HAEMORRHAGE 315 0.0073
519 PRESYNCOPE 178 0.0073
520 APHONIA 102 0.0073
521 HOSPITALISATION 1117 0.0073
522 NEPHROLITHIASIS 333 0.0073
523 URINARY RETENTION 242 0.0072
524 HYPERCHOLESTEROLAEMIA 70 0.0072
525 THROAT TIGHTNESS 196 0.0072
526 DISCOMFORT 441 0.0072
527 INITIAL INSOMNIA 74 0.0072
528 FEEDING DISORDER 146 0.0072
529 HOSPICE CARE 71 0.0072
530 CHEST PAIN 1330 0.0072
531 RENAL CYST 57 0.0072
532 PROCEDURAL COMPLICATION 55 0.0072
533 DYSURIA 264 0.0072
534 FEELING HOT 439 0.0072
535 DYSPEPSIA 702 0.0071
536 ATRIAL FIBRILLATION 694 0.0071
537 HYPOTONIA 71 0.0071
538 HAEMATOCHEZIA 392 0.0071
539 UNINTENTIONAL MEDICAL DEVICE REMOVAL 82 0.0071
540 BACK PAIN 1646 0.0071
541 DRY THROAT 72 0.0071
542 CARDIOMEGALY 87 0.0071
543 CONTUSION 679 0.0070
544 SENSATION OF FOREIGN BODY 59 0.0070
545 FACE OEDEMA 118 0.0070
546 CHRONIC KIDNEY DISEASE 530 0.0070
547 ASTHMA 784 0.0069
548 TUBULOINTERSTITIAL NEPHRITIS 130 0.0069
549 ERUCTATION 134 0.0069
550 LOW BIRTH WEIGHT BABY 55 0.0069
551 HYPERTENSION 1462 0.0069
552 SARS-COV-2 TEST POSITIVE 91 0.0069
553 BLOOD LACTATE DEHYDROGENASE INCREASED 109 0.0069
554 AUTOIMMUNE DISORDER 67 0.0069
555 FIBROMYALGIA 166 0.0068
556 DYSPHAGIA 647 0.0068
557 PYELONEPHRITIS 59 0.0068
558 RIB FRACTURE 140 0.0068
559 VITAMIN D DECREASED 58 0.0068
560 DIVERTICULITIS 188 0.0068
561 GASTROENTERITIS 98 0.0067
562 ASTHENIA 2525 0.0067
563 MUSCULOSKELETAL DISCOMFORT 115 0.0067
564 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 59 0.0067
565 INTENTIONAL PRODUCT USE ISSUE 581 0.0066
566 NECK PAIN 370 0.0066
567 PULMONARY EMBOLISM 627 0.0066
568 ABSCESS 105 0.0066
569 MOTOR DYSFUNCTION 67 0.0066
570 BLOOD IRON DECREASED 78 0.0066
571 BLOOD PRESSURE SYSTOLIC INCREASED 128 0.0066
572 SYNCOPE 656 0.0065
573 VENTRICULAR EXTRASYSTOLES 68 0.0065
574 CHOLECYSTITIS 78 0.0065
575 INABILITY TO AFFORD MEDICATION 65 0.0065
576 ERYTHEMA 1338 0.0065
577 DEVICE DISLOCATION 283 0.0065
578 OCULAR DISCOMFORT 73 0.0065
579 LETHARGY 374 0.0065
580 PALPITATIONS 756 0.0064
581 PURPURA 57 0.0064
582 SHOCK 148 0.0064
583 TRANSFUSION 67 0.0064
584 PNEUMOCYSTIS JIROVECII PNEUMONIA 64 0.0064
585 DYSPHONIA 372 0.0064
586 TASTE DISORDER 129 0.0064
587 POST PROCEDURAL HAEMORRHAGE 74 0.0064
588 SWELLING 594 0.0063
589 CARDIOVASCULAR DISORDER 161 0.0063
590 ECONOMIC PROBLEM 96 0.0063
591 SNEEZING 142 0.0063
592 PRODUCT AVAILABILITY ISSUE 144 0.0063
593 ALTERED STATE OF CONSCIOUSNESS 137 0.0063
594 FALL 2087 0.0063
595 ARTERIOSCLEROSIS 59 0.0063
596 PRESCRIBED OVERDOSE 121 0.0062
597 DIARRHOEA 4022 0.0062
598 MUCOSAL INFLAMMATION 163 0.0062
599 OESOPHAGITIS 68 0.0062
600 RENAL FAILURE 826 0.0062
601 HEPATIC ENCEPHALOPATHY 58 0.0062
602 EYELID PTOSIS 63 0.0062
603 RASH PRURITIC 336 0.0062
604 LIVER FUNCTION TEST INCREASED 133 0.0062
605 HAEMATEMESIS 157 0.0062
606 POOR QUALITY SLEEP 133 0.0062
607 RESTLESSNESS 226 0.0062
608 PRODUCT USE ISSUE 1160 0.0062
609 GENERALISED TONIC-CLONIC SEIZURE 102 0.0062
610 GASTRITIS 162 0.0062
611 MENTAL DISORDER 267 0.0061
612 HEPATIC ENZYME INCREASED 418 0.0061
613 MULTI-ORGAN FAILURE 106 0.0061
614 CONSTIPATION 1337 0.0061
615 URINARY INCONTINENCE 181 0.0061
616 PERIPHERAL SWELLING 937 0.0061
617 GASTROINTESTINAL HAEMORRHAGE 507 0.0061
618 ACUTE RESPIRATORY DISTRESS SYNDROME 107 0.0060
619 EJECTION FRACTION DECREASED 94 0.0060
620 RENAL IMPAIRMENT 508 0.0060
621 GENERAL PHYSICAL HEALTH DETERIORATION 699 0.0060
622 ORTHOSTATIC HYPOTENSION 105 0.0060
623 TINNITUS 277 0.0060
624 RESPIRATORY ARREST 166 0.0060
625 GLOMERULAR FILTRATION RATE DECREASED 74 0.0060
626 IMPAIRED GASTRIC EMPTYING 82 0.0060
627 CORONARY ARTERY DISEASE 182 0.0060
628 NEUTROPENIA 815 0.0060
629 SUBARACHNOID HAEMORRHAGE 61 0.0060
630 HERPES ZOSTER 344 0.0060
631 PRURITUS 2296 0.0060
632 SCRATCH 63 0.0060
633 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 286 0.0059
634 SCAR 101 0.0059
635 MUSCULAR WEAKNESS 669 0.0059
636 MYELODYSPLASTIC SYNDROME 85 0.0059
637 HYPERHIDROSIS 756 0.0059
638 MASS 82 0.0059
639 HYPERSOMNIA 168 0.0059
640 LACRIMATION INCREASED 177 0.0059
641 PRODUCT USE IN UNAPPROVED INDICATION 1447 0.0058
642 OFF LABEL USE 5101 0.0058
643 SLEEP DISORDER 411 0.0058
644 UPPER LIMB FRACTURE 116 0.0058
645 CARDIOMYOPATHY 86 0.0058
646 RASH PAPULAR 130 0.0058
647 ACCIDENT 69 0.0058
648 HAEMORRHAGE 604 0.0058
649 FATIGUE 4484 0.0058
650 INTESTINAL OBSTRUCTION 217 0.0058
651 HAEMORRHAGE INTRACRANIAL 86 0.0057
652 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 409 0.0057
653 THROMBOSIS 462 0.0057
654 RENAL DISORDER 266 0.0057
655 HYPOAESTHESIA 854 0.0057
656 URTICARIA 955 0.0057
657 OSTEOMYELITIS 103 0.0057
658 MUSCLE ATROPHY 72 0.0057
659 INTERSTITIAL LUNG DISEASE 275 0.0057
660 DRUG LEVEL INCREASED 94 0.0057
661 EATING DISORDER 120 0.0056
662 BURNING SENSATION 395 0.0056
663 CARDIAC FAILURE 450 0.0056
664 PLATELET COUNT INCREASED 73 0.0056
665 LYMPHADENOPATHY 198 0.0056
666 EYE PAIN 315 0.0056
667 PHOTOPHOBIA 105 0.0056
668 ABDOMINAL PAIN LOWER 141 0.0056
669 LIMB DISCOMFORT 172 0.0056
670 TREMOR 922 0.0055
671 SPLENOMEGALY 65 0.0055
672 MYOCARDIAL ISCHAEMIA 63 0.0055
673 CYTOMEGALOVIRUS INFECTION 92 0.0055
674 CEREBRAL INFARCTION 135 0.0055
675 MUSCLE RIGIDITY 66 0.0055
676 DIZZINESS 2747 0.0055
677 PULMONARY THROMBOSIS 60 0.0055
678 SWELLING FACE 358 0.0055
679 APHASIA 166 0.0055
680 SLUGGISHNESS 56 0.0055
681 HERNIA 106 0.0055
682 LOSS OF CONSCIOUSNESS 697 0.0054
683 WEIGHT INCREASED 1217 0.0054
684 AGITATION 398 0.0054
685 FAECES DISCOLOURED 117 0.0054
686 ELECTROCARDIOGRAM QT PROLONGED 194 0.0054
687 HYPERSENSITIVITY 1001 0.0054
688 IMMUNODEFICIENCY 80 0.0054
689 MALAISE 2341 0.0053
690 HEPATIC STEATOSIS 99 0.0053
691 DEVICE ISSUE 475 0.0053
692 MUSCLE TWITCHING 122 0.0053
693 PAIN 3245 0.0053
694 CHOLELITHIASIS 173 0.0053
695 NOCTURIA 64 0.0053
696 TOOTH FRACTURE 58 0.0053
697 THERAPY INTERRUPTED 375 0.0052
698 DIPLOPIA 136 0.0052
699 BLISTER 294 0.0052
700 STOMATITIS 317 0.0052
701 ORAL HERPES 102 0.0052
702 ORAL PAIN 117 0.0052
703 DEEP VEIN THROMBOSIS 339 0.0052
704 SPINAL PAIN 61 0.0052
705 MYOCLONUS 62 0.0052
706 LIP SWELLING 173 0.0052
707 DECREASED ACTIVITY 56 0.0052
708 DEVICE LEAKAGE 225 0.0052
709 NEUROPATHY PERIPHERAL 493 0.0052
710 HYPERTHYROIDISM 75 0.0052
711 RASH 2245 0.0051
712 HEART RATE IRREGULAR 116 0.0051
713 ACUTE MYELOID LEUKAEMIA 80 0.0051
714 RENAL PAIN 54 0.0051
715 DEPRESSED LEVEL OF CONSCIOUSNESS 201 0.0051
716 CONFUSIONAL STATE 821 0.0051
717 DISORIENTATION 201 0.0051
718 PAIN IN EXTREMITY 1494 0.0051
719 CARDIO-RESPIRATORY ARREST 212 0.0051
720 MYDRIASIS 65 0.0051
721 INTERNATIONAL NORMALISED RATIO INCREASED 144 0.0050
722 WOUND 141 0.0050
723 METASTASES TO CENTRAL NERVOUS SYSTEM 65 0.0050
724 RASH MACULAR 176 0.0050
725 ARRHYTHMIA 237 0.0050
726 CEREBRAL HAEMORRHAGE 179 0.0050
727 TRANSIENT ISCHAEMIC ATTACK 168 0.0050
728 CHOKING 97 0.0050
729 DYSARTHRIA 186 0.0049
730 BLOOD URINE PRESENT 93 0.0049
731 PROTEINURIA 93 0.0049
732 INFLUENZA LIKE ILLNESS 402 0.0049
733 ACUTE MYOCARDIAL INFARCTION 144 0.0049
734 RENAL FAILURE ACUTE 207 0.0049
735 ABDOMINAL DISCOMFORT 813 0.0048
736 GASTROINTESTINAL PAIN 53 0.0048
737 MELAENA 106 0.0048
738 CONDITION AGGRAVATED 1464 0.0048
739 COLITIS ULCERATIVE 215 0.0048
740 BASAL CELL CARCINOMA 75 0.0048
741 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 112 0.0048
742 INTERVERTEBRAL DISC PROTRUSION 105 0.0048
743 BLOOD PRESSURE FLUCTUATION 115 0.0048
744 PARAESTHESIA 750 0.0048
745 ANXIETY 1355 0.0048
746 SKIN REACTION 67 0.0048
747 THYROID DISORDER 73 0.0047
748 BACK DISORDER 77 0.0047
749 RESTLESS LEGS SYNDROME 86 0.0047
750 MUSCLE SPASMS 867 0.0047
751 PANCREATITIS ACUTE 106 0.0047
752 HALLUCINATION 355 0.0047
753 MUSCLE TIGHTNESS 76 0.0047
754 HEPATIC CIRRHOSIS 88 0.0047
755 RENAL INJURY 138 0.0046
756 SCIATICA 74 0.0046
757 HEAD DISCOMFORT 82 0.0046
758 METASTASES TO BONE 76 0.0046
759 PARALYSIS 66 0.0046
760 EXPOSURE DURING PREGNANCY 285 0.0046
761 NIGHT SWEATS 147 0.0046
762 IMMUNE SYSTEM DISORDER 60 0.0045
763 SKIN DISCOLOURATION 209 0.0045
764 LIVER DISORDER 201 0.0045
765 ROAD TRAFFIC ACCIDENT 188 0.0045
766 OCULAR HYPERAEMIA 213 0.0045
767 PHARYNGEAL OEDEMA 69 0.0045
768 SPEECH DISORDER 235 0.0045
769 SOMNOLENCE 901 0.0045
770 SUBDURAL HAEMATOMA 64 0.0045
771 SKIN LESION 122 0.0044
772 HIP FRACTURE 143 0.0044
773 HYPOGLYCAEMIA 215 0.0044
774 IMPAIRED HEALING 145 0.0044
775 SKIN ULCER 114 0.0044
776 SKIN DISORDER 147 0.0044
777 DRUG TOXICITY 60 0.0044
778 ANKLE FRACTURE 68 0.0044
779 CARDIAC DISORDER 409 0.0044
780 NODULE 57 0.0044
781 TOOTH EXTRACTION 54 0.0043
782 ACUTE HEPATIC FAILURE 59 0.0043
783 CATARACT 257 0.0043
784 PRODUCT PRESCRIBING ISSUE 94 0.0043
785 HEMIPARESIS 73 0.0043
786 PARANOIA 74 0.0043
787 ABDOMINAL PAIN UPPER 880 0.0043
788 TENDONITIS 66 0.0043
789 TOOTHACHE 77 0.0042
790 INCORRECT PRODUCT ADMINISTRATION DURATION 92 0.0042
791 PREGNANCY 85 0.0042
792 LYMPHOPENIA 60 0.0042
793 PRODUCT DOSE OMISSION IN ERROR 120 0.0042
794 CARDIAC FAILURE CONGESTIVE 340 0.0042
795 PLASMA CELL MYELOMA 165 0.0042
796 LACTIC ACIDOSIS 136 0.0042
797 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 230 0.0042
798 BLOOD TRIGLYCERIDES INCREASED 74 0.0042
799 BONE PAIN 245 0.0042
800 DEPRESSED MOOD 221 0.0042
801 DEVICE USE ERROR 145 0.0042
802 MATERNAL EXPOSURE DURING PREGNANCY 371 0.0042
803 THIRST 74 0.0041
804 EYE SWELLING 154 0.0041
805 DRY EYE 206 0.0041
806 JAUNDICE 111 0.0041
807 METASTASES TO LIVER 72 0.0041
808 PREMATURE BABY 123 0.0041
809 MALIGNANT NEOPLASM PROGRESSION 417 0.0041
810 PULMONARY FIBROSIS 78 0.0041
811 PANCREATITIS 213 0.0040
812 FLATULENCE 226 0.0040
813 DRY MOUTH 322 0.0040
814 PREMATURE DELIVERY 63 0.0040
815 OBESITY 63 0.0040
816 COMA 188 0.0039
817 ARTHRALGIA 1620 0.0039
818 GASTRIC ULCER 74 0.0039
819 BLOOD CREATINE PHOSPHOKINASE INCREASED 112 0.0039
820 VISION BLURRED 534 0.0039
821 DISEASE PROGRESSION 460 0.0039
822 RHABDOMYOLYSIS 162 0.0039
823 INFLAMMATION 200 0.0039
824 SWOLLEN TONGUE 121 0.0039
825 NEEDLE ISSUE 112 0.0038
826 VERTIGO 234 0.0038
827 HALLUCINATION, AUDITORY 61 0.0038
828 POLLAKIURIA 160 0.0038
829 BALANCE DISORDER 331 0.0038
830 FEELING ABNORMAL 910 0.0038
831 AGEUSIA 94 0.0038
832 SKIN CANCER 81 0.0038
833 GALLBLADDER DISORDER 67 0.0037
834 HEPATOTOXICITY 83 0.0037
835 CHROMATURIA 84 0.0037
836 LOWER LIMB FRACTURE 71 0.0037
837 OSTEOPOROSIS 152 0.0037
838 PHOTOSENSITIVITY REACTION 61 0.0037
839 NERVOUS SYSTEM DISORDER 115 0.0037
840 DERMATITIS 77 0.0037
841 INJURY 258 0.0037
842 EYE IRRITATION 210 0.0036
843 LIVER FUNCTION TEST ABNORMAL 106 0.0036
844 TOOTH DISORDER 81 0.0036
845 ABNORMAL BEHAVIOUR 144 0.0036
846 EYE PRURITUS 122 0.0036
847 MYALGIA 614 0.0036
848 UNEVALUABLE EVENT 270 0.0036
849 DIABETES MELLITUS 272 0.0036
850 DRUG INTOLERANCE 344 0.0036
851 ARTHRITIS 277 0.0035
852 CRYING 127 0.0035
853 HYPOACUSIS 150 0.0035
854 DEAFNESS 90 0.0034
855 ANHEDONIA 90 0.0034
856 DYSSTASIA 100 0.0034
857 TREATMENT NONCOMPLIANCE 187 0.0034
858 OSTEOARTHRITIS 144 0.0034
859 GAIT DISTURBANCE 645 0.0034
860 SENSORY DISTURBANCE 54 0.0034
861 IRRITABILITY 202 0.0034
862 IRRITABLE BOWEL SYNDROME 72 0.0034
863 DIABETIC KETOACIDOSIS 80 0.0033
864 ILL-DEFINED DISORDER 202 0.0033
865 ANGINA PECTORIS 95 0.0033
866 SURGERY 192 0.0033
867 TYPE 2 DIABETES MELLITUS 109 0.0032
868 GAIT INABILITY 108 0.0032
869 CHOLESTASIS 62 0.0032
870 INSOMNIA 852 0.0032
871 MUSCULOSKELETAL STIFFNESS 280 0.0032
872 JOINT SWELLING 385 0.0032
873 DYSGEUSIA 231 0.0031
874 MIDDLE INSOMNIA 58 0.0031
875 PANIC ATTACK 112 0.0031
876 BLOOD CHOLESTEROL INCREASED 143 0.0031
877 MOVEMENT DISORDER 98 0.0030
878 PERITONITIS 63 0.0030
879 ACCIDENTAL OVERDOSE 111 0.0030
880 ANGIOEDEMA 133 0.0030
881 MUSCULOSKELETAL PAIN 157 0.0030
882 SPINAL FRACTURE 60 0.0030
883 HALLUCINATION, VISUAL 63 0.0030
884 SEDATION 78 0.0030
885 BONE DISORDER 54 0.0030
886 ADVERSE EVENT 273 0.0030
887 DYSKINESIA 120 0.0029
888 DEVICE MALFUNCTION 207 0.0029
889 EMOTIONAL DISTRESS 356 0.0029
890 INCREASED APPETITE 56 0.0029
891 UNDERDOSE 212 0.0029
892 DRUG INTERACTION 459 0.0029
893 HOT FLUSH 218 0.0029
894 JOINT STIFFNESS 75 0.0029
895 VISUAL IMPAIRMENT 354 0.0029
896 INTENTIONAL PRODUCT MISUSE 250 0.0029
897 THERAPEUTIC RESPONSE SHORTENED 94 0.0028
898 MOBILITY DECREASED 203 0.0028
899 LABORATORY TEST ABNORMAL 83 0.0028
900 COGNITIVE DISORDER 130 0.0028
901 HEPATITIS 71 0.0028
902 DEMENTIA 77 0.0028
903 ECZEMA 143 0.0027
904 BLOOD GLUCOSE DECREASED 131 0.0027
905 SKIN EXFOLIATION 230 0.0027
906 ALOPECIA 535 0.0027
907 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 92 0.0027
908 SYSTEMIC LUPUS ERYTHEMATOSUS 96 0.0027
909 BLOOD GLUCOSE INCREASED 508 0.0027
910 PRODUCT PRESCRIBING ERROR 64 0.0027
911 NEOPLASM PROGRESSION 93 0.0027
912 CEREBROVASCULAR ACCIDENT 449 0.0026
913 EYE DISORDER 87 0.0026
914 MOOD SWINGS 83 0.0026
915 FEAR 70 0.0026
916 DEPRESSION 588 0.0026
917 TOXICITY TO VARIOUS AGENTS 429 0.0025
918 MEDICATION ERROR 141 0.0025
919 ARTHROPATHY 139 0.0025
920 MEMORY IMPAIRMENT 338 0.0025
921 ADVERSE DRUG REACTION 220 0.0024
922 NEOPLASM MALIGNANT 162 0.0024
923 DEATH 2077 0.0024
924 INJECTION SITE SWELLING 184 0.0024
925 INCORRECT DOSE ADMINISTERED 545 0.0024
926 NERVOUSNESS 124 0.0024
927 GLOSSODYNIA 53 0.0024
928 FEMUR FRACTURE 73 0.0024
929 DISTURBANCE IN ATTENTION 126 0.0023
930 NO ADVERSE EVENT 414 0.0023
931 EMOTIONAL DISORDER 69 0.0022
932 MOOD ALTERED 61 0.0022
933 PSYCHOTIC DISORDER 66 0.0022
934 NIGHTMARE 76 0.0022
935 DRUG INEFFECTIVE 2865 0.0022
936 DRY SKIN 287 0.0021
937 AMNESIA 139 0.0021
938 FOETAL EXPOSURE DURING PREGNANCY 172 0.0021
939 DRUG ADMINISTRATION ERROR 64 0.0021
940 SKIN IRRITATION 95 0.0021
941 EXTRA DOSE ADMINISTERED 84 0.0021
942 CONVULSION 117 0.0020
943 ANGER 69 0.0020
944 MYOCARDIAL INFARCTION 350 0.0020
945 PAIN OF SKIN 54 0.0020
946 AGGRESSION 100 0.0020
947 BLINDNESS 81 0.0020
948 VAGINAL HAEMORRHAGE 86 0.0020
949 DRUG EFFECT INCOMPLETE 70 0.0019
950 INJECTION SITE RASH 59 0.0019
951 VISUAL ACUITY REDUCED 63 0.0019
952 INJECTION SITE MASS 70 0.0019
953 INJECTION SITE PRURITUS 126 0.0019
954 INJECTION SITE ERYTHEMA 233 0.0019
955 DEVICE BREAKAGE 76 0.0019
956 OSTEONECROSIS 61 0.0019
957 THERAPY CESSATION 95 0.0018
958 OVERDOSE 384 0.0018
959 INJECTION SITE REACTION 121 0.0018
960 EXPIRED PRODUCT ADMINISTERED 56 0.0017
961 SUICIDAL IDEATION 154 0.0017
962 PRODUCT DOSE OMISSION 108 0.0017
963 WRONG TECHNIQUE IN DRUG USAGE PROCESS 60 0.0016
964 INJECTION SITE PAIN 505 0.0016
965 GASTRIC DISORDER 56 0.0016
966 INCORRECT ROUTE OF DRUG ADMINISTRATION 57 0.0016
967 DEVICE DIFFICULT TO USE 105 0.0016
968 PRODUCT QUALITY ISSUE 212 0.0016
969 THERAPEUTIC RESPONSE DECREASED 92 0.0015
970 THERAPEUTIC PRODUCT EFFECT DECREASED 67 0.0015
971 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 299 0.0015
972 DISEASE RECURRENCE 70 0.0015
973 LUNG NEOPLASM MALIGNANT 59 0.0014
974 INJECTION SITE BRUISING 114 0.0014
975 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 66 0.0014
976 INTENTIONAL OVERDOSE 90 0.0014
977 ABORTION SPONTANEOUS 56 0.0014
978 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 95 0.0013
979 RHEUMATOID ARTHRITIS 150 0.0013
980 MULTIPLE SCLEROSIS 62 0.0013
981 INJECTION SITE HAEMORRHAGE 103 0.0013
982 SUICIDE ATTEMPT 77 0.0013
983 SKIN BURNING SENSATION 89 0.0012
984 TREATMENT FAILURE 99 0.0012
985 ACNE 85 0.0011
986 MULTIPLE SCLEROSIS RELAPSE 76 0.0011
987 DRUG ABUSE 91 0.0011
988 PRODUCT STORAGE ERROR 93 0.0011
989 BREAST CANCER 95 0.0010
990 ACCIDENTAL EXPOSURE TO PRODUCT 92 0.0009
991 DRUG DOSE OMISSION 136 0.0008
992 PSORIASIS 98 0.0007